News
It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer ...
Veteran filmmaker Chandra Barot, best known for helming Amitabh Bachchan’s 1978 cult classic Don, passed away at a hospital ...
Ayodeji Adegunsoye, MD, PhD, MSc, discusses how emerging genetic insights like telomere-related mutations may reshape disease ...
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, ...
Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...
The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...
16d
Sportschosun on MSNIdiopathic pulmonary fibrosis where lung tissue hardens like a scar...Early symptoms are similar to ...According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients with idiopathic pulmonary fibrosis in Korea.Recently, the number of patients ...
Marilyn Glassberg, MD, emphasizes the need for improved community education and highlights promising new drug pathways for idiopathic pulmonary fibrosis (IPF).
Fewer patients with idiopathic pulmonary fibrosis and obstructive sleep apnea died vs. patients with idiopathic pulmonary ...
Boehringer Ingelheim reported positive growth in the first half of 2025, with group net sales growing by 6.3%* to EUR 14.0 billion.
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results